P251 Small bowel capsule endoscopy is a valuable diagnostic tool in isolated terminal ileitis
M. FREITAS1,2,3, T. Cúrdia Gonçalves1,2,3, P. Boal Carvalho1,2,3, F. Dias de Castro1,2,3, B. Rosa1,2,3, M.J. Moreira1,2,3, J. Cotter1,2,3
1Gastroenterology Department, Hospital da Senhora da Oliveira, Guimarães, Portugal, 2PT Government Associate Laboratory, ICVS/3B’s, Braga/Guimarães, Portugal, 3Life and Health Sciences Research Institute ICVS, School of Medicine, University of Minho, Braga, Portugal
Terminal ileitis (TI), is a common condition in clinical practice and may be associated with a wide variety of diseases. Small bowel capsule endoscopy (SBCE) is a valuable diagnostic tool for small bowel diseases; however, data regarding its diagnostic impact on isolated TI are sparse. The aim of the study was to evaluate the diagnostic value of SBCE for isolated TI detected during ileocolonoscopy.
Retrospective study including consecutive patients undergoing SBCE after diagnosis of TI without colonic mucosal abnormalities on ileocolonoscopy between January 2016 and September 2019. Demographic, clinical, biochemical, endoscopic and imaging data were collected.
One hundred and two patients with isolated ileitis on ileocolonoscopy were included. Positive findings on SBCE were found in 84 (82.4%) patients, being ulcers the most common finding (76.5%). Endoscopic abnormalities proximal to terminal ileum were found in 36.3% of patients. After SBCE, 63.7% of patients had a final diagnosis, Crohn’s disease (CD) was the most common (34.3%), followed by NSAIDs enteropathy (12.7%). Elevated faecal calprotectin (
SBCE revealed a high diagnostic yield in patients with isolated ileitis on ileocolonoscopy enabling a definite diagnosis in almost two-thirds of patients. Approximately one-third of patients had findings proximal to terminal ileum and a similar percentage was diagnosed with CD. In patients with isolated ileitis on ileocolonoscopy, SBCE should be considered to evaluate small bowel lesions, particularly when there is an elevated faecal calprotectin, even when other clinical, imagiological or laboratorial abnormalities are absent.